Member Info for parkez

The 13th is upon us next week, today is the last friday before the transfer of Woodfords fund to Schroder. I admit i was expecting the notifications today, fridays always seem a good day for such things.
Now considering there are at least another 15 companies that will be getting such notifications (imo) and these will be considered (imo) market sensitive, will they have to be released to the market at the same time...or am i over complicating matters?

Thanks for that info, always happy to learn.

You sure that was a buy, my small top up at 16.03 was a genuine buy...large trades like that usually pay a premium. Unless it's your trade I would suggest a genuine sell.

https://www.lse.co.uk/rns/TRX/orthopuret-xt-tendon-uk-clinical-trial-approval-y25r8eog83fiho4.html

http://otp.investis.com/clients/uk/tissueregenix1/rns/regulatory-story.aspx?newsid=507885&cid=208

https://clinicaltrials.gov/ct2/show/NCT03562299

https://www.tissueregenix.com/media/2009/edison-orthopaedics-outlook-280716.pdf

Yes another RNS where the objective appears to be to drive down the sp. Rather contradictive action if a placing is forthcoming...but certainly made to sound that way.
sp reacting accordingly today...no surprises there.

B2HS2L.
You would think so, but we know we can not take things for granted.
Only time will tell.

B2HS2L,
In total agreement with you on that, licensing is the way to go and i,m sure they are in motion. Licence agreements are not straight forward.The licencee will want an instant roi ...They will organise there end first before signing, upfront payments possible.
The "structuring" mention did not say debt structuring.

Orthopure XT has i believe been on going since 2015, forecast ce mark approval 2017 onwards...last forecast end of 2019. Todays report states expected soon.

"On 17 October 2019, TRX issued a trading statement to update the market with
respect to its performance and potential outcome for 4Q’19. This was important
because the 3Q’19 sales performance had an impact on the company’s loan facility,
which had to be subsequently renegotiated. On 22 January 2020, TRX issued a
second trading statement, given that the final outcome for 2019 was better than
previously indicated, following a particularly strong final month of the year. "

Putting on my rose tinted and reading into this statement and the successful structuring statement, just wondering if in fact it is TRX who are putting the demands on Midcap.
They seemed happy with the original loan agreement,,had to be renegotiated due to targets not being met....in fact things were better than expected. Are TRX actually saying to Midcap...we want better terms, a new deal or we are going elsewhere?

"Consistent throughout this transitional period has been the demand for its products.
The planned introduction of extended product lines, primarily for the urogynaecology
markets, coupled with further Group Purchasing Organisations (GPOs) taking
coverage in US hospitals to ca.95%, helped boost demand. However, while there is
undoubtedly pent-up demand for its orthopaedic products, customers need to be
sure that the business is capable of meeting their needs prior to committing to firm
orders. With the supply chain reorganisation successfully completed, significant
improvements in the availability and quality of donor tissue, and the additional
production capabilities, the expectation is that further contracts can be secured in 2020.

Like that part...PENT-UP DEMAND.

"Funding: The board and management are working closely with their advisors
to obtain an injection in capital. Dependent on structuring, a positive outcome
could potentially enable the company to draw down the remaining tranches
within the MidCap loan facility."
NOTICE, the word "recapitalisation" has been replaced by structuring?

Cant say as i have seen a report like this actually RNSed...Anyone else come across such an event?

Sorry thats TXP!! NOT trx...doh

The decisions you make...Actually had £10k in TRX @ 13p and sold to put into here.
Thats life as they say...Do your research...but most of all have some patience!!

Basically Woodford had two funds, one now closed (woodford equity) and one now under new management (woodford patient capital trust). These holdings were combined to show a holding of 26% in TRX.
This appears to be 19.98% ,( the now Link holding) was in the Patient Capital Trust and 6.2% in the Equity fund.
The 13th sees Schroder take over the Patient Capital Trust and therefore the 19.98% holding in TRX.
The 6.2% has been sold on the open market to repay the Equity funds holders.
Hope this helps.

Will repost my sunday post.
My understanding of the situation regarding Link.
Woodford investment management held % TRX in Woodford Equity Income Fund AND Woodford Patient Capital Trust.
Woodford Investment management was first suspended and then folded.
Woodford Equity income was closed and assets sold to repay investors.
Woodford Patient Capital Trust was found new management.
8TH July notification states Woodford held 26% and reduced to 22.16%, the 22.16% was reduced further to below 5%.
Link solutions then notified the uptake of the 19.98%.
I am reading into this the 19.98% was held in The Patient Capital Trust.(the sold % in Woodford equity)
So Woodford Equity Investment % sold , Woodford Patient Trust % transferred to Link( awaiting transfer to Schroders) because at this time Woodford Management no longer in business.
October 2019 stated Schroders were to be the new management of Woodford Patient Trust...this is now due to take place 13th FEB 2020.
Sometime between monday and Feb 13th we will get a tr1 notification stating Link fully out and Schroders holding 19.98%

https://www.lse.co.uk/rns/TRX/tissue-regenix-group-holdings-in-company-ms6qho9org4u1fp.html
https://www.investorschronicle.co.uk/funds-etfs/2019/06/05/what-lf-woodford-equity-income-s-suspension-means-for-you/
https://www.lse.co.uk/rns/TRX/holdings-in-company-6c3bqslvs3sy3fr.html
https://www.lse.co.uk/rns/TRX/holdings-in-company-e3d9i2q2a8x6xj1.html

https://woodfordfunds.com/funds/wpct/

The fact that Link are still holding is infact old news.
As stated that will be clarified on or around the 13th.

Short term pain for long term gain it appears. Seems a placing is coming...Question is, has that already been organised and todays RNS is an attempt to justify....OR todays RNS is the start of some positives to raise the sp for the future placing?

I do not make sp predictions, if i could do that i would be rich. All i will say is roll on the 13th!